文献速递血栓与止血

整合趋化因子与机器学习算法用于原发免疫性血小板减少症的诊断与出血评估:一项前瞻性队列研究

Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study.
PubMed 文献 · Br J Haematol · 2024-09-10

该前瞻性研究采用Luminex法检测发现队列60例ITP与17例非ITP患者血浆趋化因子,并用机器学习筛选诊断与出血评估标志物,随后在验证队列(43例ITP、19例非ITP)用酶联免疫吸附试验确认。结果提示CCL20、白细胞介素-2、CCL26、CCL25、CXCL1可能有助于ITP诊断,CCL21、CXCL8、CXCL10、CCL8、CCL3、CCL15可能用于评估出血风险。

要点

  • 发现队列中机器学习识别CCL20、白细胞介素-2、CCL26、CCL25、CXCL1为ITP诊断的潜在指标。
  • CCL21、CXCL8、CXCL10、CCL8、CCL3、CCL15被识别为评估ITP出血风险的生物标志物。
  • 上述结果在验证队列(43例ITP和19例非ITP)中经酶联免疫吸附试验确认。

核心结论

  • 研究提示特定趋化因子有望作为ITP患者诊断和出血评估的潜在生物标志物。

研究设计与样本

  • 前瞻性分析,发现队列纳入60例ITP患者和17例非ITP的血小板减少症患者,采用基于Luminex的检测法量化血浆多种趋化因子浓度。
  • 发现队列中比较了12例伴出血发作的ITP患者(ITP-B,定义为ITP-2016出血分级≥2级)与33例无出血发作的ITP患者(ITP-NB,定义为ITP-2016出血分级≤1级)。
  • 验证队列纳入43例ITP患者和19例非ITP患者,采用酶联免疫吸附试验确认结果。

主要发现

  • 机器学习算法识别CCL20、白细胞介素-2、CCL26、CCL25和CXCL1为准确诊断ITP的有前景指标。
  • 机器学习算法识别CCL21、CXCL8、CXCL10、CCL8、CCL3和CCL15为评估ITP患者出血风险的生物标志物。
  • 验证队列采用酶联免疫吸附试验确认了上述结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder, and chemokines have been shown to be dysregulated in autoimmune disorders. We conducted a prospective analysis to identify potential chemokines that could enhance the diagnostic accuracy and bleeding evaluation in ITP patients. In the discovery cohort, a Luminex-based assay was employed to quantify concentrations of plasma multiple chemokines. These levels were subjected to comparative analysis using a cohort of 60 ITP patients and 17 patients with thrombocytopenia other than ITP (non-ITP). Additionally, comparative evaluation was conducted between a subgroup of 12 ITP patients characterised by bleeding episodes (ITP-B, as defined by an ITP-2016 bleeding grade ≥2) and 33 ITP patients without bleeding episodes (ITP-NB, as defined by an ITP-2016 bleeding grade ≤1). Machine learning algorithms further identified CCL20, interleukin-2, CCL26, CCL25, and CXCL1 as promising indicators for accurate diagnosis of ITP and CCL21, CXCL8, CXCL10, CCL8, CCL3, and CCL15 as biomarkers for assessing bleeding risk in ITP patients. The results were confirmed using enzyme-linked immunosorbent assays in a validation cohort (43 ITP patients and 19 non-ITP patients). Overall, the findings suggest that specific chemokines show promise as potential biomarkers for diagnosis and bleeding evaluation in ITP patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wen Q, Sun T, Chen J, et al. Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study. Br J Haematol. 2024. PMID: 39253817. doi:10.1111/bjh.19745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。